(Q37238940)

English

Induction vs. escalating therapy in multiple sclerosis: practical implications

scientific article published on September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

1 reference

Europe PubMed Central

Induction vs. escalating therapy in multiple sclerosis: practical implications (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

multiple sclerosis

0 references

1

object named as

Giancarlo Comi

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

publication date

1 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Neurological Sciences

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

29 Suppl 2

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

S253-5

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis

1 reference

https://api.crossref.org/works/10.1007%2FS10072-008-0954-X

21 January 2018

A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18690509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18690509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety

1 reference

https://pubmed.ncbi.nlm.nih.gov/18690509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinically isolated syndrome: the rationale for early treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18690509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous haematopoietic stem-cell transplantation in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18690509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natalizumab: targeting alpha4-integrins in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18690509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical follow-up of 304 patients with multiple sclerosis three years after mitoxantrone treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18690509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10072-008-0954-X

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37238940&oldid=2200073745"